Results 41 to 50 of about 1,884 (153)

Efficacy and Safety of 0.05% Halometasone/1% Triclosan Cream Versus 0.1% Mometasone Furoate Cream in the Treatment of truncal vitiligo: A Retrospective Study

open access: yesInternational Journal of Dermatology and Venerology, 2021
. Objective:. To retrospectively evaluate efficacy and safety of 0.05% halometasone/1% triclosan cream (Hal/TCS) in treating truncal vitiligo of children and adolescents. Methods:.
Shu-Zhen Qi, Xue-Si Zeng, Shu-Chang Hu
doaj   +1 more source

StrataXRT Versus Mepitel Film for Prevention of Acute Radiation Dermatitis in Postmastectomy Radiotherapy: A Pooled Analysis of Intra‐Patient Randomised Trials

open access: yesJournal of Medical Radiation Sciences, EarlyView.
In 120 patients receiving postmastectomy radiotherapy, each irradiated chest wall was divided into medial and lateral halves, which were randomised to Mepitel Film or StrataXRT. Mepitel Film reduced grade 2–3 acute radiation dermatitis and clinician‐assessed erythema and moist desquamation over time.
Shing Fung Lee   +6 more
wiley   +1 more source

Validasi Metode Analisa Residu Mometasone Furoate dan CIP100 Setelah Proses Pembersihan Peralatan Produksi di Industri Farmasi XYZ [PDF]

open access: yes, 2019
Pada penelitian ini, metode Analisa HPLC dan Total Organic Carbon (TOC) telah dikembangkan dan divalidasi untuk penentuan jumlah residu Mometasone furoate dan CIP100 pada permukaan peralatan produksi krim Mometasone furoate 0,1% dan untuk mengkonfirmasi ...
Arintowibowo, Amaandika Galih
core   +1 more source

Successful Treatment of Refractory Lichen Amyloidosus With Dupilumab

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Lichen amyloidosis (LA) is a chronic, pruritic dermatosis with papillary dermal amyloid deposition. Standard therapies often fail, and most reports of dupilumab in LA involve patients with concomitant atopic dermatitis. We report a 32‐year‐old man with refractory, non‐atopic LA who had failed topical corticosteroids, tacrolimus, phototherapy ...
Sohrab Elahwiesy   +5 more
wiley   +1 more source

Mometasone furoate nasal spray for nasal polyposis

open access: yes, 2007
Nasal polyposis occurs in 2-4% of the general population and is associated with significant socioeconomic costs due to severe nasal/airway symptoms that impair quality of life.
Stjärne, P,
core   +1 more source

Evaluation of rheological and mucoadhesive properties of selected nasal spray preparations with mometasone furoate [PDF]

open access: yes, 2017
Intranasal preparations with mometasone furoate are recognised to be highly efficient and safe in both adults and children. Commercially available nasal sprays are characterised by thixotropic and mucoadhesive properties – factors ensuring effortless ...
Katarzyna Winnicka   +3 more
core   +1 more source

Labial adhesions: A novel therapeutic approach

open access: yesAnnals of Medical Science and Research, 2022
Labial adhesion is a common condition found in girls before puberty. All the patients (n = 15) in this series were diagnosed clinically, and routine blood and urine examinations were normal.
Kali Sankar Bhattacharyya   +4 more
doaj   +1 more source

Plasma Cell Mucositis: A 20‐Year Retrospective Review at a Tertiary Center

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Plasma cell mucositis (PCM) is a rare, chronic inflammatory condition of mucosal surfaces that is likely underdiagnosed and underreported, with limited data on its clinical characteristics, extracavitary involvement, and treatment outcomes.
Miguel A. Aristizabal‐Torres   +4 more
wiley   +1 more source

When Treatment Meets Natural History: Understanding Early Dermatitis‐Related Adverse Events in Systemic Atopic Dermatitis Trials

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Biologics and Janus kinase (JAK) inhibitors have transformed the management of atopic dermatitis (AD), yet some patients experience early worsening of disease activity during treatment initiation. In clinical trials, these events are typically recorded as treatment‐emergent adverse events (TEAEs), most commonly coded as “atopic dermatitis”. We
Diego Ruiz Dasilva   +17 more
wiley   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy